date,title,source
Oct-18-18,"Recent Analysis Shows Lantheus, Editas Medicine, CorMedix, DXP Enterprises, Peabody Energy, and CommScope Holding Market Influences  Renewed Outlook, Key Drivers of Growth",GlobeNewswire
Oct-26-18,Editas Medicine (EDIT) Stock Moves -0.95%: What You Should Know,Zacks
Oct-31-18,Editas Medicine to Host Conference Call Discussing Third Quarter 2018 Corporate Update and Results,GlobeNewswire
Oct-31-18,Is a Beat in Store for Editas (EDIT) This Earnings Season?,Zacks
Nov-05-18,Here's Why CRISPR Stocks Fell as Much as 40.7% in October,Motley Fool
Nov-05-18,5 Drug/Biotech Stocks Set to Trump Estimates in Q3 Earnings,Zacks
Nov-07-18,Cambridge's Editas asks FDA to start gene editing trial,American City Business Journals
Nov-07-18,"Editas Medicine, Inc. (EDIT) Q3 2018 Earnings Conference Call Transcript",Motley Fool
Nov-07-18,"Editas Medicine (EDIT) Reports Q3 Loss, Tops Revenue Estimates",Zacks
Nov-07-18,Editas: 3Q Earnings Snapshot,Associated Press
Nov-07-18,Editas Medicine Announces Third Quarter 2018 Results and Update,GlobeNewswire
Nov-08-18,Editas Medicine Makes Steady Progress in Another Solid Quarter,Motley Fool
Nov-12-18,"Analysis: Positioning to Benefit within IDEXX Laboratories, Editas Medicine, Arconic, Cardtronics, Cloudera, and BMC Stock  Research Highlights Growth, Revenue, and Consolidated Results",GlobeNewswire
